(Q33366916)

English

Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After Thromboc

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After Thromboc (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

thrombocytopenia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

heparin-induced thrombocytopenia

1 reference

based on heuristic

inferred from title

Erik Magnus Ohman

1

object named as

E Magnus Ohman

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Christopher B. Granger

2

object named as

Christopher B Granger

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Kevin J Anstrom

14

object named as

Kevin J Anstrom

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Neal S. Kleiman

7

object named as

Neal S Kleiman

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Lawrence Rice

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Charles S Abrams

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Richard C Becker

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Peter B Berger

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

David Moliterno

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Stephan Moll

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Jo E Rodgers

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Stephen S Steinhubl

11

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Victor F Tapson

12

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Peter Sinnaeve

13

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry

15

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

1 February 2005

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Journal of Thrombosis and Thrombolysis

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

11-19

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

https://scigraph.springernature.com/pub.10.1007/s11239-005-0850-7

0 references

Heparin-induced thrombocytopenia. An unexpected response to treatment of consumption coagulopathy

1 reference

https://api.crossref.org/works/10.1007%2FS11239-005-0850-7

21 January 2018

Thrombocytopenia occurring during the administration of heparin. A prospective study in 52 patients

1 reference

https://api.crossref.org/works/10.1007%2FS11239-005-0850-7

21 January 2018

The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1007%2FS11239-005-0850-7

21 January 2018

Delayed-onset heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1007%2FS11239-005-0850-7

21 January 2018

Delayed-onset heparin-induced thrombocytopenia and thrombosis

1 reference

https://api.crossref.org/works/10.1007%2FS11239-005-0850-7

21 January 2018

Recombinant hirudin in clinical practice: focus on lepirudin.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-005-0850-7

21 January 2018

Preventing complications in heparin-induced thrombocytopenia. Alternative anticoagulants are improving patient outcomes

1 reference

https://api.crossref.org/works/10.1007%2FS11239-005-0850-7

21 January 2018

Prognostic significance of thrombocytopenia during hirudin and heparin therapy in acute coronary syndrome without ST elevation: Organization to Assess Strategies for Ischemic Syndromes (OASIS-2)study

1 reference

https://api.crossref.org/works/10.1007%2FS11239-005-0850-7

21 January 2018

Acute profound thrombocytopenia after C7E3 Fab (abciximab) therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-005-0850-7

21 January 2018

Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome. The platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial experience

1 reference

https://api.crossref.org/works/10.1007%2FS11239-005-0850-7

21 January 2018

Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Heparin-Associated Thrombocytopenia Study (HAT) investigators.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-005-0850-7

21 January 2018

Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study

1 reference

https://api.crossref.org/works/10.1007%2FS11239-005-0850-7

21 January 2018

Arterial Embolism Occurring During Systemic Heparin Therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11239-005-0850-7

21 January 2018

Arterial embolism occurring during systemic heparin therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15976962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of recombinant hirudin as antithrombotic treatment in patients with heparin-induced thrombocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15976962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin-induced thrombocytopenia: an overview

1 reference

https://pubmed.ncbi.nlm.nih.gov/15976962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Temporal aspects of heparin-induced thrombocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15976962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15976962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15976962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data

1 reference

https://pubmed.ncbi.nlm.nih.gov/15976962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15976962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations

1 reference

https://pubmed.ncbi.nlm.nih.gov/15976962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15976962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin-associated thrombocytopenia: a comparison of three heparin preparations

1 reference

https://pubmed.ncbi.nlm.nih.gov/15976962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical importance of thrombocytopenia occurring in the hospital phase after administration of thrombolytic therapy for acute myocardial infarction. The Thrombolysis and Angioplasty in Myocardial Infarction Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15976962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin induced thrombocytopenia: eight cases with thrombotic-hemorrhagic complications

1 reference

https://pubmed.ncbi.nlm.nih.gov/15976962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15976962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin-induced immune thrombocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15976962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Laboratory testing for heparin-induced thrombocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15976962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade

1 reference

https://pubmed.ncbi.nlm.nih.gov/15976962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HEPARIN--A CAUSE OF ARTERIAL EMBOLI?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15976962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin-induced thrombocytopenia/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through FcgammaRIIA.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15976962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15976962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin-induced thrombocytopenia: patient profiles and clinical manifestations

1 reference

https://pubmed.ncbi.nlm.nih.gov/15976962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Venous thromboembolism in heparin-induced thrombocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15976962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin-induced thrombocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15976962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15976962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 14-year study of heparin-induced thrombocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15976962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin

1 reference

https://pubmed.ncbi.nlm.nih.gov/15976962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin-induced thrombocytopenia: confirmation of diagnosis with in vitro methods

1 reference

https://pubmed.ncbi.nlm.nih.gov/15976962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-platelet factor 4/heparin antibodies: an independent predictor of 30-day myocardial infarction after acute coronary ischemic syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/15976962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization. Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15976962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11239-005-0850-7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33366916&oldid=1649550536"